Abstract |
Acute myeloid leukemia (AML) is a heterogeneous disease whose prognosis is mainly related to the biological risk conferred by cytogenetics and molecular profiling. In elderly patients (⩾60 years) with normal karyotype AML miR-3151 have been identified as a prognostic factor. However, miR-3151 prognostic value has not been examined in younger AML patients. In the present work, we have studied miR-3151 alone and in combination with BAALC, its host gene, in a cohort of 181 younger intermediate-risk AML (IR-AML) patients. Patients with higher expression of miR-3151 had shorter overall survival (P=0.0025), shorter leukemia-free survival (P=0.026) and higher cumulative incidence of relapse (P=0.082). Moreover, in the multivariate analysis miR-3151 emerged as independent prognostic marker in both the overall series and within the unfavorable molecular prognostic category. Interestingly, the combined determination of both miR-3151 and BAALC improved this prognostic stratification, with patients with low levels of both parameters showing a better outcome compared with those patients harboring increased levels of one or both markers (P=0.003). In addition, we studied the microRNA expression profile associated with miR-3151 identifying a six- microRNA signature. In conclusion, the analysis of miR-3151 and BAALC expression may well contribute to an improved prognostic stratification of younger patients with IR-AML.
|
Authors | M Díaz-Beyá, S Brunet, J Nomdedéu, A Cordeiro, M Tormo, L Escoda, J M Ribera, M Arnan, I Heras, D Gallardo, J Bargay, M P Queipo de Llano, O Salamero, J M Martí, A Sampol, C Pedro, M Hoyos, M Pratcorona, J J Castellano, M Nomdedeu, R M Risueño, J Sierra, M Monzó, A Navarro, J Esteve |
Journal | Blood cancer journal
(Blood Cancer J)
Vol. 5
Pg. e352
(Oct 02 2015)
ISSN: 2044-5385 [Electronic] United States |
PMID | 26430723
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- BAALC protein, human
- Biomarkers, Tumor
- MIRN3151 microRNA, human
- MicroRNAs
- Neoplasm Proteins
|
Topics |
- Adolescent
- Adult
- Aged
- Biomarkers, Tumor
(genetics)
- Cytogenetic Analysis
- Disease-Free Survival
- Female
- Humans
- Kaplan-Meier Estimate
- Leukemia, Myeloid, Acute
(genetics, mortality)
- Male
- MicroRNAs
(genetics)
- Middle Aged
- Neoplasm Proteins
(genetics)
- Prognosis
- Proportional Hazards Models
- Risk Factors
- Transcriptome
- Young Adult
|